- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x JC8: 6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide(Non-covalent)
- 7 x PO4: PHOSPHATE ION(Non-functional Binders)
PO4.2: 7 residues within 4Å:- Chain A: K.42, S.167, E.170, E.210
- Chain B: D.94, R.96
- Ligands: JC8.1
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:S.167, A:E.170, A:E.170, A:E.210
- Salt bridges: A:K.42, B:R.96
PO4.9: 7 residues within 4Å:- Chain B: K.42, S.167, E.170, E.210
- Chain C: D.94, R.96
- Ligands: JC8.8
5 PLIP interactions:4 interactions with chain B, 1 interactions with chain C- Hydrogen bonds: B:E.170, B:E.170, B:E.210
- Salt bridges: B:K.42, C:R.96
PO4.10: 10 residues within 4Å:- Chain B: A.109, Y.110, S.111, S.112, W.164
- Chain C: Q.55, V.70, L.119, A.137
- Ligands: EDO.17
5 PLIP interactions:2 interactions with chain B, 3 interactions with chain C- Hydrogen bonds: B:A.109, B:S.112, C:Q.55, C:Q.55, C:Q.55
PO4.19: 7 residues within 4Å:- Chain C: K.42, S.167, E.170, E.210
- Chain D: D.94, R.96
- Ligands: JC8.18
5 PLIP interactions:4 interactions with chain C, 1 interactions with chain D- Hydrogen bonds: C:S.167, C:E.170, C:E.170
- Salt bridges: C:K.42, D:R.96
PO4.20: 8 residues within 4Å:- Chain C: A.109, Y.110, S.111, S.112, W.164
- Chain D: Q.55, L.119, A.137
5 PLIP interactions:1 interactions with chain D, 4 interactions with chain C- Hydrogen bonds: D:Q.55, C:Y.110, C:Y.110, C:S.112, C:S.112
PO4.27: 8 residues within 4Å:- Chain D: K.42, S.167, E.170, E.210, Y.212
- Chain E: D.94, R.96
- Ligands: JC8.26
5 PLIP interactions:4 interactions with chain D, 1 interactions with chain E- Hydrogen bonds: D:S.167, D:E.170, D:Y.212
- Salt bridges: D:K.42, E:R.96
PO4.36: 7 residues within 4Å:- Chain A: D.94, R.96
- Chain E: K.42, S.167, E.170, E.210
- Ligands: JC8.35
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain E- Hydrogen bonds: A:D.94, E:S.167, E:E.170, E:E.210
- Salt bridges: A:R.96, E:K.42
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 7 residues within 4Å:- Chain A: A.109, Y.110, S.111, S.112
- Chain B: Q.55, V.70
- Ligands: EDO.7
Ligand excluded by PLIPEDO.4: 7 residues within 4Å:- Chain A: P.38, G.39, P.40, Y.166
- Chain B: L.23, F.95, R.96
Ligand excluded by PLIPEDO.5: 5 residues within 4Å:- Chain A: L.46, T.47, R.76, W.77, K.78
Ligand excluded by PLIPEDO.7: 7 residues within 4Å:- Chain A: T.108, A.109, S.112, P.115, V.116
- Chain B: L.119
- Ligands: EDO.3
Ligand excluded by PLIPEDO.11: 8 residues within 4Å:- Chain B: P.38, G.39, P.40, Y.166
- Chain C: L.23, F.95, R.96
- Ligands: EDO.15
Ligand excluded by PLIPEDO.12: 6 residues within 4Å:- Chain B: P.45, L.46, T.47, R.76, W.77, K.78
Ligand excluded by PLIPEDO.13: 7 residues within 4Å:- Chain B: Y.110, G.162, S.163, Y.205, Y.212, I.213, D.214
Ligand excluded by PLIPEDO.14: 6 residues within 4Å:- Chain B: T.49, L.50, G.51, Q.74, R.76, D.176
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain B: T.41, K.42, D.43, E.170
- Chain C: D.94
- Ligands: EDO.11
Ligand excluded by PLIPEDO.17: 7 residues within 4Å:- Chain B: T.108, A.109, S.112, R.114, V.116
- Chain C: L.119
- Ligands: PO4.10
Ligand excluded by PLIPEDO.21: 8 residues within 4Å:- Chain C: P.38, G.39, P.40, Y.166
- Chain D: L.23, D.94, F.95, R.96
Ligand excluded by PLIPEDO.22: 6 residues within 4Å:- Chain C: P.45, L.46, T.47, R.76, W.77, K.78
Ligand excluded by PLIPEDO.23: 4 residues within 4Å:- Chain B: P.115
- Chain C: V.116, Q.117, V.118
Ligand excluded by PLIPEDO.25: 6 residues within 4Å:- Chain C: T.108, A.109, S.112, P.115, V.116
- Chain D: L.119
Ligand excluded by PLIPEDO.28: 10 residues within 4Å:- Chain D: T.108, A.109, Y.110, S.111, S.112, M.143, W.164
- Chain E: Q.55, V.70, L.119
Ligand excluded by PLIPEDO.29: 9 residues within 4Å:- Chain D: P.38, G.39, P.40, T.41, Y.166
- Chain E: L.23, F.95, R.96
- Ligands: EDO.30
Ligand excluded by PLIPEDO.30: 6 residues within 4Å:- Chain D: T.41, K.42, D.43, E.170
- Chain E: D.94
- Ligands: EDO.29
Ligand excluded by PLIPEDO.32: 6 residues within 4Å:- Chain D: A.109, S.112, R.114, P.115, V.116
- Chain E: L.119
Ligand excluded by PLIPEDO.33: 8 residues within 4Å:- Chain A: V.118, L.119
- Chain E: A.109, S.112, R.114, P.115, V.116
- Ligands: EDO.37
Ligand excluded by PLIPEDO.34: 8 residues within 4Å:- Chain D: T.64, N.65
- Chain E: D.56, I.57, V.58, Y.186, S.189, K.190
Ligand excluded by PLIPEDO.37: 9 residues within 4Å:- Chain A: Q.55, V.70, A.137
- Chain E: A.109, Y.110, S.111, S.112, M.143
- Ligands: EDO.33
Ligand excluded by PLIPEDO.38: 7 residues within 4Å:- Chain A: L.23, F.95, R.96
- Chain E: P.38, G.39, P.40, Y.166
Ligand excluded by PLIPEDO.39: 5 residues within 4Å:- Chain E: P.45, L.46, T.47, W.77, K.78
Ligand excluded by PLIPEDO.40: 6 residues within 4Å:- Chain E: T.49, L.50, G.51, Q.74, R.76, D.176
Ligand excluded by PLIP- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6: 2 residues within 4Å:- Chain A: G.90, N.91
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:N.91
NAG.16: 1 residues within 4Å:- Chain B: N.91
No protein-ligand interaction detected (PLIP)NAG.24: 2 residues within 4Å:- Chain C: G.90, N.91
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:N.91
NAG.31: 2 residues within 4Å:- Chain D: G.90, N.91
No protein-ligand interaction detected (PLIP)NAG.41: 2 residues within 4Å:- Chain E: G.90, N.91
No protein-ligand interaction detected (PLIP)- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bueno, R.V. et al., Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta Crystallogr.,Sect.D (2022)
- Release Date
- 2020-03-18
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.50 Å
- Oligo State
- homo-pentamer
- Ligands
- 5 x JC8: 6-[5-[(1~{R},2~{R},4~{S})-7-azabicyclo[2.2.1]heptan-2-yl]-2-fluoranyl-pyridin-3-yl]pyridine-3-carboxamide(Non-covalent)
- 7 x PO4: PHOSPHATE ION(Non-functional Binders)
- 24 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Bueno, R.V. et al., Interactions between 2'-fluoro-(carbamoylpyridinyl)deschloroepibatidine analogues and acetylcholine-binding protein inform on potent antagonist activity against nicotinic receptors. Acta Crystallogr.,Sect.D (2022)
- Release Date
- 2020-03-18
- Peptides
- Soluble acetylcholine receptor: ABCDE
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E